BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31860798)

  • 1. A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
    Pons G; Riba D; Casasampere M; Izquierdo E; Abad JL; Fabriàs G; Rodríguez Ortega PG; López-González JJ; Montejo M; Casas J; Delgado A
    J Org Chem; 2020 Jan; 85(2):419-429. PubMed ID: 31860798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the inhibition of sphingosine-1-phosphate lyase by stabilized reaction intermediates and stereodefined azido phosphates.
    Sanllehí P; Abad JL; Bujons J; Casas J; Delgado A
    Eur J Med Chem; 2016 Nov; 123():905-915. PubMed ID: 27543882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors.
    Sanllehí P; Abad JL; Casas J; Bujons J; Delgado A
    Bioorg Med Chem; 2016 Sep; 24(18):4381-4389. PubMed ID: 27475537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
    Dinges J; Harris CM; Wallace GA; Argiriadi MA; Queeney KL; Perron DC; Dominguez E; Kebede T; Desino KE; Patel H; Vasudevan A
    Bioorg Med Chem Lett; 2016 May; 26(9):2297-302. PubMed ID: 27020302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a mechanism-based inhibitor of a 3-deoxy-D-arabino heptulosonate 7-phosphate synthase.
    Walker SR; Parker EJ
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2951-4. PubMed ID: 16563755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats.
    Harris CM; Mittelstadt S; Banfor P; Bousquet P; Duignan DB; Gintant G; Hart M; Kim Y; Segreti J
    J Pharmacol Exp Ther; 2016 Oct; 359(1):151-8. PubMed ID: 27519818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).
    Sanllehí P; Abad JL; Casas J; Delgado A
    Chem Phys Lipids; 2016 May; 197():69-81. PubMed ID: 26200919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casuarine stereoisomers from achiral substrates: chemoenzymatic synthesis and inhibitory properties.
    Concia AL; Gómez L; Parella T; Joglar J; Clapés P
    J Org Chem; 2014 Jun; 79(11):5386-9. PubMed ID: 24810734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
    Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
    J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups.
    Azéma L; Lherbet C; Baudoin C; Blonski C
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3440-3. PubMed ID: 16632348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthase.
    Harrison AN; Reichau S; Parker EJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):907-11. PubMed ID: 22204912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a mechanism-based inhibitor of KDO8P synthase.
    Belakhov V; Dovgolevsky E; Rabkin E; Shulami S; Shoham Y; Baasov T
    Carbohydr Res; 2004 Jan; 339(2):385-92. PubMed ID: 14698897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first fluorogenic sensor for sphingosine-1-phosphate lyase activity in intact cells.
    Sanllehí P; Casasampere M; Abad JL; Fabriàs G; López O; Bujons J; Casas J; Delgado A
    Chem Commun (Camb); 2017 May; 53(39):5441-5444. PubMed ID: 28462976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyase.
    Kashem MA; Wa C; Wolak JP; Grafos NS; Ryan KR; Sanville-Ross ML; Fogarty KE; Rybina IV; Shoultz A; Molinaro T; Desai SN; Rajan A; Huber JD; Nelson RM
    Assay Drug Dev Technol; 2014 Jun; 12(5):293-302. PubMed ID: 24846303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels.
    Ohtoyo M; Tamura M; Machinaga N; Muro F; Hashimoto R
    Lipids; 2016 Oct; 51(10):1207-1216. PubMed ID: 27585475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932).
    Bagdanoff JT; Donoviel MS; Nouraldeen A; Carlsen M; Jessop TC; Tarver J; Aleem S; Dong L; Zhang H; Boteju L; Hazelwood J; Yan J; Bednarz M; Layek S; Owusu IB; Gopinathan S; Moran L; Lai Z; Kramer J; Kimball SD; Yalamanchili P; Heydorn WE; Frazier KS; Brooks B; Brown P; Wilson A; Sonnenburg WK; Main A; Carson KG; Oravecz T; Augeri DJ
    J Med Chem; 2010 Dec; 53(24):8650-62. PubMed ID: 21090716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of new potent KDO-8-phosphate synthetase inhibitors.
    Coutrot P; Dumarçay S; Finance C; Tabyaoui M; Tabyaoui B; Grison C
    Bioorg Med Chem Lett; 1999 Apr; 9(7):949-52. PubMed ID: 10230617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity.
    Bandhuvula P; Tam YY; Oskouian B; Saba JD
    J Biol Chem; 2005 Oct; 280(40):33697-700. PubMed ID: 16118221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.